TG Therapeutics (TGTX) Competitors $34.20 -1.27 (-3.58%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$34.21 +0.01 (+0.04%) As of 06:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TGTX vs. TEVA, SMMT, ITCI, GMAB, RDY, VTRS, MRNA, QGEN, ASND, and ROIVShould you be buying TG Therapeutics stock or one of its competitors? The main competitors of TG Therapeutics include Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Moderna (MRNA), Qiagen (QGEN), Ascendis Pharma A/S (ASND), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. TG Therapeutics vs. Teva Pharmaceutical Industries Summit Therapeutics Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Viatris Moderna Qiagen Ascendis Pharma A/S Roivant Sciences Teva Pharmaceutical Industries (NYSE:TEVA) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends. Does the media prefer TEVA or TGTX? In the previous week, Teva Pharmaceutical Industries had 23 more articles in the media than TG Therapeutics. MarketBeat recorded 34 mentions for Teva Pharmaceutical Industries and 11 mentions for TG Therapeutics. TG Therapeutics' average media sentiment score of 1.56 beat Teva Pharmaceutical Industries' score of 1.01 indicating that TG Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teva Pharmaceutical Industries 21 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive TG Therapeutics 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer TEVA or TGTX? Teva Pharmaceutical Industries currently has a consensus price target of $24.43, indicating a potential upside of 47.38%. TG Therapeutics has a consensus price target of $40.80, indicating a potential upside of 19.30%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher probable upside, equities analysts plainly believe Teva Pharmaceutical Industries is more favorable than TG Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13TG Therapeutics 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has stronger earnings and valuation, TEVA or TGTX? TG Therapeutics has lower revenue, but higher earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$16.62B1.13-$1.64B-$1.15-14.41TG Therapeutics$386.39M14.05$12.67M$0.24142.50 Is TEVA or TGTX more profitable? TG Therapeutics has a net margin of -5.42% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat TG Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-9.91% 42.46% 6.65% TG Therapeutics -5.42%-8.32%-3.40% Which has more risk and volatility, TEVA or TGTX? Teva Pharmaceutical Industries has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 2.21, indicating that its share price is 121% more volatile than the S&P 500. Does the MarketBeat Community prefer TEVA or TGTX? Teva Pharmaceutical Industries received 679 more outperform votes than TG Therapeutics when rated by MarketBeat users. However, 76.27% of users gave TG Therapeutics an outperform vote while only 67.88% of users gave Teva Pharmaceutical Industries an outperform vote. CompanyUnderperformOutperformTeva Pharmaceutical IndustriesOutperform Votes133867.88% Underperform Votes63332.12% TG TherapeuticsOutperform Votes65976.27% Underperform Votes20523.73% Do institutionals and insiders believe in TEVA or TGTX? 54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are held by institutional investors. 0.5% of Teva Pharmaceutical Industries shares are held by insiders. Comparatively, 10.6% of TG Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryTeva Pharmaceutical Industries beats TG Therapeutics on 10 of the 19 factors compared between the two stocks. Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TGTX vs. The Competition Export to ExcelMetricTG TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.43B$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E Ratio-341.978.9226.8419.71Price / Sales14.05253.80392.34117.39Price / Cash353.9065.8538.2534.62Price / Book32.266.466.794.50Net Income$12.67M$143.98M$3.23B$248.18M7 Day Performance1.82%2.03%1.53%0.20%1 Month Performance-9.98%4.11%10.06%12.37%1 Year Performance93.22%-2.87%16.72%7.04% TG Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TGTXTG Therapeutics3.8224 of 5 stars$34.20-3.6%$40.80+19.3%+106.0%$5.43B$386.39M-341.97290Positive NewsTEVATeva Pharmaceutical Industries3.2848 of 5 stars$17.92+5.8%$24.43+36.4%-0.1%$20.31B$16.62B-12.3636,800Positive NewsOptions VolumeSMMTSummit Therapeutics3.1705 of 5 stars$25.26+5.4%$37.40+48.1%+478.8%$18.76B$700,000.00-90.21110Positive NewsITCIIntra-Cellular Therapies0.8742 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560News CoverageGMABGenmab A/S3.4301 of 5 stars$19.93+2.9%$39.17+96.5%-29.6%$12.78B$21.64B11.451,660Positive NewsHigh Trading VolumeRDYDr. Reddy's Laboratories2.3254 of 5 stars$13.93+3.9%$17.00+22.1%+4.0%$11.62B$311.31B22.1724,800Positive NewsGap UpVTRSViatris2.0724 of 5 stars$8.96+2.2%$10.50+17.2%-22.6%$10.63B$14.33B-12.1137,000Trending NewsMRNAModerna4.5362 of 5 stars$25.70+6.0%$53.95+109.9%-82.0%$9.94B$3.14B-2.773,900Trending NewsQGENQiagen3.987 of 5 stars$42.92+2.5%$48.42+12.8%-3.5%$9.54B$1.98B119.526,030Positive NewsASNDAscendis Pharma A/S3.504 of 5 stars$154.43+2.1%$216.07+39.9%+28.7%$9.42B$368.70M-21.75640Positive NewsROIVRoivant Sciences2.1398 of 5 stars$10.99+3.3%$17.50+59.2%-2.8%$7.84B$122.59M-73.26860Positive NewsUpcoming Earnings Related Companies and Tools Related Companies Teva Pharmaceutical Industries Alternatives Summit Therapeutics Alternatives Intra-Cellular Therapies Alternatives Genmab A/S Alternatives Dr. Reddy's Laboratories Alternatives Viatris Alternatives Moderna Alternatives Qiagen Alternatives Ascendis Pharma A/S Alternatives Roivant Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TGTX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TGTX Stock Free TGTX Stock Alerts